Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase NA 6Phase 2 6Phase EARLY_PHASE1 4Phase 3 3Phase 4 1Phase 2/3 1

Status

Completed 4Terminated 1Recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 3Breast 2Head & Neck 1

Conditions

Breast Neoplasms 2Thyroid Neoplasms 1Renal Insufficiency, Chronic 1Prostatic Neoplasms 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × perflutren × Clear all
NCT04136912 2025-10-06

3-D Super Resolution Ultrasound Microvascular Imaging

UNC Lineberger Comprehensive Cancer Center

Phase 2 Terminated
27 enrolled 12 charts
BreastHead & Neck

Breast Neoplasms, Thyroid Neoplasms

NCT02967458 2025-04-30

Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study

Thomas Jefferson University

Phase 2 Completed
55 enrolled 8 charts
Genitourinary

Prostatic Neoplasms

NCT06185972 2024-09-27

Novel Magnetic Resonance Imaging-Guided Ultrasound-Stimulated Microbubble Radiation Treatment for Patients With Chest-Wall and Breast Cancer

Sunnybrook Health Sciences Centre

Phase 2 Recruiting
200 enrolled
Breast

Breast Neoplasms

NCT03907657 2024-05-21

CEUS-VHL

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
15 enrolled 7 charts

Renal Insufficiency, Chronic

NCT04021238 2023-11-13

Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
25 enrolled 28 charts
Genitourinary

Kidney Neoplasms

NCT01062178 2016-03-08

Efficacy of Ultrasound Contrast Agent to Assess Renal Masses

University Health Network, Toronto

Phase 2 Completed
167 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡